Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Tabernero

Showing results (1-10 of 576) with videos related to

Pageof 58
Sort By:
ESMO Open|April 10, 2019
Two-way traffic: aligning expectations with current realities in oncology. Mid-term ESMO Presidency considerationsJosep Tabernero
Molecular Cancer Research : MCR|March 22, 2007
The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agentsJosep Tabernero
ESMO Open|November 16, 2018
Biosimilars in oncologyJosep Tabernero
ESMO Open|December 1, 2018
All change: closing the gender gap in oncologyJosep Tabernero
Current Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep Tabernero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical developmentJosep Tabernero, Teresa Macarulla
Nature Reviews. Clinical Oncology|June 15, 2016
Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRCJosep Tabernero, Ramon Salazar
Cancer Cell|December 15, 2020
The Effective Targeting of KRAS<sup>G12C</sup> ElusivenessElena Elez, Josep Tabernero
JACC. Cardiooncology|August 16, 2021
Back-to-Back Discovery, Co-Precision, and PreventionBarbara Casadei, Josep Tabernero
Cancer Discovery|July 8, 2017
Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the DarknessJordi Rodon, Josep Tabernero
Pageof 58

Showing results (1-10 of 576) with videos related to

Sort By:
Pageof 58
ESMO Open|April 10, 2019
Two-way traffic: aligning expectations with current realities in oncology. Mid-term ESMO Presidency considerationsJosep Tabernero
Molecular Cancer Research : MCR|March 22, 2007
The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agentsJosep Tabernero
ESMO Open|November 16, 2018
Biosimilars in oncologyJosep Tabernero
ESMO Open|December 1, 2018
All change: closing the gender gap in oncologyJosep Tabernero
Current Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep Tabernero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical developmentJosep Tabernero, Teresa Macarulla
Nature Reviews. Clinical Oncology|June 15, 2016
Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRCJosep Tabernero, Ramon Salazar
Cancer Cell|December 15, 2020
The Effective Targeting of KRAS<sup>G12C</sup> ElusivenessElena Elez, Josep Tabernero
JACC. Cardiooncology|August 16, 2021
Back-to-Back Discovery, Co-Precision, and PreventionBarbara Casadei, Josep Tabernero
Cancer Discovery|July 8, 2017
Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the DarknessJordi Rodon, Josep Tabernero
Pageof 58